Communications Biology-期刊论坛，投稿经验-MedSci.cn

[GetPortalCommentsPageByObjectIdResponse(id=2209514, encodeId=4de22209514ac, content=投稿一个多月后收到审稿意见，4个审稿人，共计三十几条意见，给了六个月的时间来返修。虽然影响因子有点低，但审稿严格，难度还是蛮大的，总感觉性价比不太高。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=85, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=05323119086, createdName=xyzt, createdTime=Wed Jun 12 16:11:14 CST 2024, time=2024-06-12, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2159600, encodeId=0c1b21596007b, content=更新一下，已经原则性接收啦，现在再对应要求改改格式和figures，应该没什么大问题了，更新真的能攒人品啊。 Stage Start Date Waiting for Revision 23rd Sep 23 Decision Made 23rd Sep 23 Editor Review Started 12th Sep 23 Initial Manuscript Review Started 12th Sep 23 Editor Assigned 12th Sep 23 Submission 11th Sep 23 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=115, replyNumber=11, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ad078632381, createdName=ms9000000957475675, createdTime=Mon Sep 25 16:03:17 CST 2023, time=2023-09-25, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2235332, encodeId=e8762235332d7, content=偏重的研究方向：肿瘤转移机制 经验分享：11月3号投稿，好运好运, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=28, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=5b1b5432110, createdName=ms9000001101107383, createdTime=Tue Nov 05 17:33:43 CST 2024, time=2024-11-05, status=1, ipAttribution=加利福尼亚), GetPortalCommentsPageByObjectIdResponse(id=2235109, encodeId=1b7b223510961, content=24.11.2 submission 希望好运！！！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=24, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTKN1Ot5ibrSUopzI45n7IsLlBeWMbiaN8fDt7NMcfXtn0xCml7jksRXicqvXd8FDPd6xbdP9PFpLDQhg/132, createdBy=20965199906, createdName=扣1992, createdTime=Mon Nov 04 16:00:02 CST 2024, time=2024-11-04, status=1, ipAttribution=黑龙江省), GetPortalCommentsPageByObjectIdResponse(id=2226728, encodeId=278d2226e287a, content=审稿速度:6.0 | 投稿命中率:50.0 偏重的研究方向：肿瘤 经验分享：是不是送审回来后under review的状态就没了了，我送审后一直Editor Review Started快两周了，under review的状态就没了，好焦虑呀, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=43, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=32728759448, createdName=ms2000001407604797, createdTime=Fri Sep 20 11:12:30 CST 2024, time=2024-09-20, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2221474, encodeId=929e22214e4e4, content=已经Decision Made20天了，等得好苦啊 Decision Made 30th Jul 24 Editor Review Started 26th Jul 24 Initial Manuscript Review Started 10th Jul 24 Editor Assigned 8th Jul 24 Submission 5th Jul 24, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=89, replyNumber=14, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f6df8321644, createdName=ms3000001082848798, createdTime=Tue Aug 20 10:12:22 CST 2024, time=2024-08-20, status=1, ipAttribution=辽宁), GetPortalCommentsPageByObjectIdResponse(id=2143170, encodeId=63cd21431e002, content=大佬们觉得这个期刊和昆虫学1区的PBP和PMS哪个好一点啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=98, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3b328275001, createdName=ms6000000883616809, createdTime=Fri Jun 16 17:11:05 CST 2023, time=2023-06-16, status=1, ipAttribution=安徽省), GetPortalCommentsPageByObjectIdResponse(id=2185092, encodeId=3def2185092bd, content=审稿速度:2.0 | 投稿命中率:25.0 偏重的研究方向：肿瘤生物学 经验分享：经验分享，第一轮 Stage Start Date Revision Received 31st Jan 24 Waiting for Revision 31st Jan 24 Decision Made 30th Jan 24 Editor Review Started 13th Jan 24 Initial Manuscript Review Started 8th Jan 24 Editor Assigned 8th Jan 24 Submission 28th Dec 23, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=78, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=608d6458298, createdName=ms1000000620292943, createdTime=Wed Jan 31 20:14:45 CST 2024, time=2024-01-31, status=1, ipAttribution=福建省), GetPortalCommentsPageByObjectIdResponse(id=2222798, encodeId=e8042222e9868, content=偏重的研究方向：肿瘤治疗 经验分享：请问under review一般要等多久呀？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=79, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=5e932497746, createdName=12490d82m03暂无昵称, createdTime=Wed Aug 28 10:56:51 CST 2024, time=2024-08-28, status=1, ipAttribution=湖南省), GetPortalCommentsPageByObjectIdResponse(id=2224533, encodeId=271f222453368, content=审稿速度:12.0 | 投稿命中率:25.0 偏重的研究方向：内质网应激 经验分享：终于接受了，总共三轮审稿，3名审稿人，其中有一个审稿人的问了很多细节的问题，意见真的很专业。WB结果需要没有裁剪过的图片，我是提供了切膜以后拼接起来的图片。个人感觉第一轮审稿很慢，但是投稿体验比之前的国产sci好多了，接受以后10天左右proof，online和检索都非常快速。 第一轮： Revision Received 29th Apr 24 Waiting for Revision 26th Apr 24 Decision Made 26th Apr 24 Editor Review Started 9th Feb 24 Initial Manuscript Review Started 6th Feb 24 Editor Assigned 5th Feb 24 Submission 24th Jan 24 第二轮： Revision Received 6th Aug 24 Waiting for Revision 19th Jul 24 Decision Made 19th Jul 24 Editor Review Started 5th Jul 24 Initial Manuscript Review Started 5th Jul 24 Editor Assigned 5th Jul 24 Submission 3rd Jul 24 第三轮： Post Decision 28th Aug 24 Decision Made 28th Aug 24 Editor Review Started 28th Aug 24 Initial Manuscript Review Started 28th Aug 24 Editor Assigned 28th Aug 24 Submission 6th Aug 24, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=53, replyNumber=12, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3f2e6150418, createdName=ms8000001193267048, createdTime=Sat Sep 07 03:21:06 CST 2024, time=2024-09-07, status=1, ipAttribution=德克萨斯)]

2024-06-12 xyzt 来自广东省

投稿一个多月后收到审稿意见，4个审稿人，共计三十几条意见，给了六个月的时间来返修。虽然影响因子有点低，但审稿严格，难度还是蛮大的，总感觉性价比不太高。

85 7

展开7条回复

[GetPortalCommentsPageByObjectIdResponse(id=2209514, encodeId=4de22209514ac, content=投稿一个多月后收到审稿意见，4个审稿人，共计三十几条意见，给了六个月的时间来返修。虽然影响因子有点低，但审稿严格，难度还是蛮大的，总感觉性价比不太高。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=85, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=05323119086, createdName=xyzt, createdTime=Wed Jun 12 16:11:14 CST 2024, time=2024-06-12, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2159600, encodeId=0c1b21596007b, content=更新一下，已经原则性接收啦，现在再对应要求改改格式和figures，应该没什么大问题了，更新真的能攒人品啊。 Stage Start Date Waiting for Revision 23rd Sep 23 Decision Made 23rd Sep 23 Editor Review Started 12th Sep 23 Initial Manuscript Review Started 12th Sep 23 Editor Assigned 12th Sep 23 Submission 11th Sep 23 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=115, replyNumber=11, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ad078632381, createdName=ms9000000957475675, createdTime=Mon Sep 25 16:03:17 CST 2023, time=2023-09-25, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2235332, encodeId=e8762235332d7, content=偏重的研究方向：肿瘤转移机制 经验分享：11月3号投稿，好运好运, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=28, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=5b1b5432110, createdName=ms9000001101107383, createdTime=Tue Nov 05 17:33:43 CST 2024, time=2024-11-05, status=1, ipAttribution=加利福尼亚), GetPortalCommentsPageByObjectIdResponse(id=2235109, encodeId=1b7b223510961, content=24.11.2 submission 希望好运！！！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=24, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTKN1Ot5ibrSUopzI45n7IsLlBeWMbiaN8fDt7NMcfXtn0xCml7jksRXicqvXd8FDPd6xbdP9PFpLDQhg/132, createdBy=20965199906, createdName=扣1992, createdTime=Mon Nov 04 16:00:02 CST 2024, time=2024-11-04, status=1, ipAttribution=黑龙江省), GetPortalCommentsPageByObjectIdResponse(id=2226728, encodeId=278d2226e287a, content=审稿速度:6.0 | 投稿命中率:50.0 偏重的研究方向：肿瘤 经验分享：是不是送审回来后under review的状态就没了了，我送审后一直Editor Review Started快两周了，under review的状态就没了，好焦虑呀, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=43, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=32728759448, createdName=ms2000001407604797, createdTime=Fri Sep 20 11:12:30 CST 2024, time=2024-09-20, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2221474, encodeId=929e22214e4e4, content=已经Decision Made20天了，等得好苦啊 Decision Made 30th Jul 24 Editor Review Started 26th Jul 24 Initial Manuscript Review Started 10th Jul 24 Editor Assigned 8th Jul 24 Submission 5th Jul 24, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=89, replyNumber=14, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f6df8321644, createdName=ms3000001082848798, createdTime=Tue Aug 20 10:12:22 CST 2024, time=2024-08-20, status=1, ipAttribution=辽宁), GetPortalCommentsPageByObjectIdResponse(id=2143170, encodeId=63cd21431e002, content=大佬们觉得这个期刊和昆虫学1区的PBP和PMS哪个好一点啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=98, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3b328275001, createdName=ms6000000883616809, createdTime=Fri Jun 16 17:11:05 CST 2023, time=2023-06-16, status=1, ipAttribution=安徽省), GetPortalCommentsPageByObjectIdResponse(id=2185092, encodeId=3def2185092bd, content=审稿速度:2.0 | 投稿命中率:25.0 偏重的研究方向：肿瘤生物学 经验分享：经验分享，第一轮 Stage Start Date Revision Received 31st Jan 24 Waiting for Revision 31st Jan 24 Decision Made 30th Jan 24 Editor Review Started 13th Jan 24 Initial Manuscript Review Started 8th Jan 24 Editor Assigned 8th Jan 24 Submission 28th Dec 23, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=78, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=608d6458298, createdName=ms1000000620292943, createdTime=Wed Jan 31 20:14:45 CST 2024, time=2024-01-31, status=1, ipAttribution=福建省), GetPortalCommentsPageByObjectIdResponse(id=2222798, encodeId=e8042222e9868, content=偏重的研究方向：肿瘤治疗 经验分享：请问under review一般要等多久呀？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=79, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=5e932497746, createdName=12490d82m03暂无昵称, createdTime=Wed Aug 28 10:56:51 CST 2024, time=2024-08-28, status=1, ipAttribution=湖南省), GetPortalCommentsPageByObjectIdResponse(id=2224533, encodeId=271f222453368, content=审稿速度:12.0 | 投稿命中率:25.0 偏重的研究方向：内质网应激 经验分享：终于接受了，总共三轮审稿，3名审稿人，其中有一个审稿人的问了很多细节的问题，意见真的很专业。WB结果需要没有裁剪过的图片，我是提供了切膜以后拼接起来的图片。个人感觉第一轮审稿很慢，但是投稿体验比之前的国产sci好多了，接受以后10天左右proof，online和检索都非常快速。 第一轮： Revision Received 29th Apr 24 Waiting for Revision 26th Apr 24 Decision Made 26th Apr 24 Editor Review Started 9th Feb 24 Initial Manuscript Review Started 6th Feb 24 Editor Assigned 5th Feb 24 Submission 24th Jan 24 第二轮： Revision Received 6th Aug 24 Waiting for Revision 19th Jul 24 Decision Made 19th Jul 24 Editor Review Started 5th Jul 24 Initial Manuscript Review Started 5th Jul 24 Editor Assigned 5th Jul 24 Submission 3rd Jul 24 第三轮： Post Decision 28th Aug 24 Decision Made 28th Aug 24 Editor Review Started 28th Aug 24 Initial Manuscript Review Started 28th Aug 24 Editor Assigned 28th Aug 24 Submission 6th Aug 24, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=53, replyNumber=12, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3f2e6150418, createdName=ms8000001193267048, createdTime=Sat Sep 07 03:21:06 CST 2024, time=2024-09-07, status=1, ipAttribution=德克萨斯)]

2023-09-25 ms9000000957475675 来自江苏省

更新一下，已经原则性接收啦，现在再对应要求改改格式和figures，应该没什么大问题了，更新真的能攒人品啊。
Stage Start Date
Waiting for Revision 23rd Sep 23
Decision Made 23rd Sep 23
Editor Review Started 12th Sep 23
Initial Manuscript Review Started 12th Sep 23
Editor Assigned 12th Sep 23
Submission 11th Sep 23

115 11

展开11条回复

[GetPortalCommentsPageByObjectIdResponse(id=2209514, encodeId=4de22209514ac, content=投稿一个多月后收到审稿意见，4个审稿人，共计三十几条意见，给了六个月的时间来返修。虽然影响因子有点低，但审稿严格，难度还是蛮大的，总感觉性价比不太高。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=85, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=05323119086, createdName=xyzt, createdTime=Wed Jun 12 16:11:14 CST 2024, time=2024-06-12, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2159600, encodeId=0c1b21596007b, content=更新一下，已经原则性接收啦，现在再对应要求改改格式和figures，应该没什么大问题了，更新真的能攒人品啊。 Stage Start Date Waiting for Revision 23rd Sep 23 Decision Made 23rd Sep 23 Editor Review Started 12th Sep 23 Initial Manuscript Review Started 12th Sep 23 Editor Assigned 12th Sep 23 Submission 11th Sep 23 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=115, replyNumber=11, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ad078632381, createdName=ms9000000957475675, createdTime=Mon Sep 25 16:03:17 CST 2023, time=2023-09-25, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2235332, encodeId=e8762235332d7, content=偏重的研究方向：肿瘤转移机制 经验分享：11月3号投稿，好运好运, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=28, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=5b1b5432110, createdName=ms9000001101107383, createdTime=Tue Nov 05 17:33:43 CST 2024, time=2024-11-05, status=1, ipAttribution=加利福尼亚), GetPortalCommentsPageByObjectIdResponse(id=2235109, encodeId=1b7b223510961, content=24.11.2 submission 希望好运！！！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=24, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTKN1Ot5ibrSUopzI45n7IsLlBeWMbiaN8fDt7NMcfXtn0xCml7jksRXicqvXd8FDPd6xbdP9PFpLDQhg/132, createdBy=20965199906, createdName=扣1992, createdTime=Mon Nov 04 16:00:02 CST 2024, time=2024-11-04, status=1, ipAttribution=黑龙江省), GetPortalCommentsPageByObjectIdResponse(id=2226728, encodeId=278d2226e287a, content=审稿速度:6.0 | 投稿命中率:50.0 偏重的研究方向：肿瘤 经验分享：是不是送审回来后under review的状态就没了了，我送审后一直Editor Review Started快两周了，under review的状态就没了，好焦虑呀, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=43, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=32728759448, createdName=ms2000001407604797, createdTime=Fri Sep 20 11:12:30 CST 2024, time=2024-09-20, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2221474, encodeId=929e22214e4e4, content=已经Decision Made20天了，等得好苦啊 Decision Made 30th Jul 24 Editor Review Started 26th Jul 24 Initial Manuscript Review Started 10th Jul 24 Editor Assigned 8th Jul 24 Submission 5th Jul 24, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=89, replyNumber=14, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f6df8321644, createdName=ms3000001082848798, createdTime=Tue Aug 20 10:12:22 CST 2024, time=2024-08-20, status=1, ipAttribution=辽宁), GetPortalCommentsPageByObjectIdResponse(id=2143170, encodeId=63cd21431e002, content=大佬们觉得这个期刊和昆虫学1区的PBP和PMS哪个好一点啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=98, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3b328275001, createdName=ms6000000883616809, createdTime=Fri Jun 16 17:11:05 CST 2023, time=2023-06-16, status=1, ipAttribution=安徽省), GetPortalCommentsPageByObjectIdResponse(id=2185092, encodeId=3def2185092bd, content=审稿速度:2.0 | 投稿命中率:25.0 偏重的研究方向：肿瘤生物学 经验分享：经验分享，第一轮 Stage Start Date Revision Received 31st Jan 24 Waiting for Revision 31st Jan 24 Decision Made 30th Jan 24 Editor Review Started 13th Jan 24 Initial Manuscript Review Started 8th Jan 24 Editor Assigned 8th Jan 24 Submission 28th Dec 23, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=78, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=608d6458298, createdName=ms1000000620292943, createdTime=Wed Jan 31 20:14:45 CST 2024, time=2024-01-31, status=1, ipAttribution=福建省), GetPortalCommentsPageByObjectIdResponse(id=2222798, encodeId=e8042222e9868, content=偏重的研究方向：肿瘤治疗 经验分享：请问under review一般要等多久呀？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=79, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=5e932497746, createdName=12490d82m03暂无昵称, createdTime=Wed Aug 28 10:56:51 CST 2024, time=2024-08-28, status=1, ipAttribution=湖南省), GetPortalCommentsPageByObjectIdResponse(id=2224533, encodeId=271f222453368, content=审稿速度:12.0 | 投稿命中率:25.0 偏重的研究方向：内质网应激 经验分享：终于接受了，总共三轮审稿，3名审稿人，其中有一个审稿人的问了很多细节的问题，意见真的很专业。WB结果需要没有裁剪过的图片，我是提供了切膜以后拼接起来的图片。个人感觉第一轮审稿很慢，但是投稿体验比之前的国产sci好多了，接受以后10天左右proof，online和检索都非常快速。 第一轮： Revision Received 29th Apr 24 Waiting for Revision 26th Apr 24 Decision Made 26th Apr 24 Editor Review Started 9th Feb 24 Initial Manuscript Review Started 6th Feb 24 Editor Assigned 5th Feb 24 Submission 24th Jan 24 第二轮： Revision Received 6th Aug 24 Waiting for Revision 19th Jul 24 Decision Made 19th Jul 24 Editor Review Started 5th Jul 24 Initial Manuscript Review Started 5th Jul 24 Editor Assigned 5th Jul 24 Submission 3rd Jul 24 第三轮： Post Decision 28th Aug 24 Decision Made 28th Aug 24 Editor Review Started 28th Aug 24 Initial Manuscript Review Started 28th Aug 24 Editor Assigned 28th Aug 24 Submission 6th Aug 24, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=53, replyNumber=12, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3f2e6150418, createdName=ms8000001193267048, createdTime=Sat Sep 07 03:21:06 CST 2024, time=2024-09-07, status=1, ipAttribution=德克萨斯)]

2024-11-05 ms9000001101107383 来自加利福尼亚

偏重的研究方向：肿瘤转移机制
经验分享：11月3号投稿，好运好运

28 8

展开8条回复

[GetPortalCommentsPageByObjectIdResponse(id=2209514, encodeId=4de22209514ac, content=投稿一个多月后收到审稿意见，4个审稿人，共计三十几条意见，给了六个月的时间来返修。虽然影响因子有点低，但审稿严格，难度还是蛮大的，总感觉性价比不太高。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=85, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=05323119086, createdName=xyzt, createdTime=Wed Jun 12 16:11:14 CST 2024, time=2024-06-12, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2159600, encodeId=0c1b21596007b, content=更新一下，已经原则性接收啦，现在再对应要求改改格式和figures，应该没什么大问题了，更新真的能攒人品啊。 Stage Start Date Waiting for Revision 23rd Sep 23 Decision Made 23rd Sep 23 Editor Review Started 12th Sep 23 Initial Manuscript Review Started 12th Sep 23 Editor Assigned 12th Sep 23 Submission 11th Sep 23 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=115, replyNumber=11, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ad078632381, createdName=ms9000000957475675, createdTime=Mon Sep 25 16:03:17 CST 2023, time=2023-09-25, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2235332, encodeId=e8762235332d7, content=偏重的研究方向：肿瘤转移机制 经验分享：11月3号投稿，好运好运, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=28, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=5b1b5432110, createdName=ms9000001101107383, createdTime=Tue Nov 05 17:33:43 CST 2024, time=2024-11-05, status=1, ipAttribution=加利福尼亚), GetPortalCommentsPageByObjectIdResponse(id=2235109, encodeId=1b7b223510961, content=24.11.2 submission 希望好运！！！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=24, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTKN1Ot5ibrSUopzI45n7IsLlBeWMbiaN8fDt7NMcfXtn0xCml7jksRXicqvXd8FDPd6xbdP9PFpLDQhg/132, createdBy=20965199906, createdName=扣1992, createdTime=Mon Nov 04 16:00:02 CST 2024, time=2024-11-04, status=1, ipAttribution=黑龙江省), GetPortalCommentsPageByObjectIdResponse(id=2226728, encodeId=278d2226e287a, content=审稿速度:6.0 | 投稿命中率:50.0 偏重的研究方向：肿瘤 经验分享：是不是送审回来后under review的状态就没了了，我送审后一直Editor Review Started快两周了，under review的状态就没了，好焦虑呀, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=43, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=32728759448, createdName=ms2000001407604797, createdTime=Fri Sep 20 11:12:30 CST 2024, time=2024-09-20, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2221474, encodeId=929e22214e4e4, content=已经Decision Made20天了，等得好苦啊 Decision Made 30th Jul 24 Editor Review Started 26th Jul 24 Initial Manuscript Review Started 10th Jul 24 Editor Assigned 8th Jul 24 Submission 5th Jul 24, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=89, replyNumber=14, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f6df8321644, createdName=ms3000001082848798, createdTime=Tue Aug 20 10:12:22 CST 2024, time=2024-08-20, status=1, ipAttribution=辽宁), GetPortalCommentsPageByObjectIdResponse(id=2143170, encodeId=63cd21431e002, content=大佬们觉得这个期刊和昆虫学1区的PBP和PMS哪个好一点啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=98, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3b328275001, createdName=ms6000000883616809, createdTime=Fri Jun 16 17:11:05 CST 2023, time=2023-06-16, status=1, ipAttribution=安徽省), GetPortalCommentsPageByObjectIdResponse(id=2185092, encodeId=3def2185092bd, content=审稿速度:2.0 | 投稿命中率:25.0 偏重的研究方向：肿瘤生物学 经验分享：经验分享，第一轮 Stage Start Date Revision Received 31st Jan 24 Waiting for Revision 31st Jan 24 Decision Made 30th Jan 24 Editor Review Started 13th Jan 24 Initial Manuscript Review Started 8th Jan 24 Editor Assigned 8th Jan 24 Submission 28th Dec 23, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=78, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=608d6458298, createdName=ms1000000620292943, createdTime=Wed Jan 31 20:14:45 CST 2024, time=2024-01-31, status=1, ipAttribution=福建省), GetPortalCommentsPageByObjectIdResponse(id=2222798, encodeId=e8042222e9868, content=偏重的研究方向：肿瘤治疗 经验分享：请问under review一般要等多久呀？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=79, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=5e932497746, createdName=12490d82m03暂无昵称, createdTime=Wed Aug 28 10:56:51 CST 2024, time=2024-08-28, status=1, ipAttribution=湖南省), GetPortalCommentsPageByObjectIdResponse(id=2224533, encodeId=271f222453368, content=审稿速度:12.0 | 投稿命中率:25.0 偏重的研究方向：内质网应激 经验分享：终于接受了，总共三轮审稿，3名审稿人，其中有一个审稿人的问了很多细节的问题，意见真的很专业。WB结果需要没有裁剪过的图片，我是提供了切膜以后拼接起来的图片。个人感觉第一轮审稿很慢，但是投稿体验比之前的国产sci好多了，接受以后10天左右proof，online和检索都非常快速。 第一轮： Revision Received 29th Apr 24 Waiting for Revision 26th Apr 24 Decision Made 26th Apr 24 Editor Review Started 9th Feb 24 Initial Manuscript Review Started 6th Feb 24 Editor Assigned 5th Feb 24 Submission 24th Jan 24 第二轮： Revision Received 6th Aug 24 Waiting for Revision 19th Jul 24 Decision Made 19th Jul 24 Editor Review Started 5th Jul 24 Initial Manuscript Review Started 5th Jul 24 Editor Assigned 5th Jul 24 Submission 3rd Jul 24 第三轮： Post Decision 28th Aug 24 Decision Made 28th Aug 24 Editor Review Started 28th Aug 24 Initial Manuscript Review Started 28th Aug 24 Editor Assigned 28th Aug 24 Submission 6th Aug 24, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=53, replyNumber=12, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3f2e6150418, createdName=ms8000001193267048, createdTime=Sat Sep 07 03:21:06 CST 2024, time=2024-09-07, status=1, ipAttribution=德克萨斯)]

2024-11-04 扣1992 来自黑龙江省

24.11.2 submission
希望好运！！！

24 1

展开1条回复

[GetPortalCommentsPageByObjectIdResponse(id=2209514, encodeId=4de22209514ac, content=投稿一个多月后收到审稿意见，4个审稿人，共计三十几条意见，给了六个月的时间来返修。虽然影响因子有点低，但审稿严格，难度还是蛮大的，总感觉性价比不太高。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=85, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=05323119086, createdName=xyzt, createdTime=Wed Jun 12 16:11:14 CST 2024, time=2024-06-12, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2159600, encodeId=0c1b21596007b, content=更新一下，已经原则性接收啦，现在再对应要求改改格式和figures，应该没什么大问题了，更新真的能攒人品啊。 Stage Start Date Waiting for Revision 23rd Sep 23 Decision Made 23rd Sep 23 Editor Review Started 12th Sep 23 Initial Manuscript Review Started 12th Sep 23 Editor Assigned 12th Sep 23 Submission 11th Sep 23 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=115, replyNumber=11, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ad078632381, createdName=ms9000000957475675, createdTime=Mon Sep 25 16:03:17 CST 2023, time=2023-09-25, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2235332, encodeId=e8762235332d7, content=偏重的研究方向：肿瘤转移机制 经验分享：11月3号投稿，好运好运, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=28, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=5b1b5432110, createdName=ms9000001101107383, createdTime=Tue Nov 05 17:33:43 CST 2024, time=2024-11-05, status=1, ipAttribution=加利福尼亚), GetPortalCommentsPageByObjectIdResponse(id=2235109, encodeId=1b7b223510961, content=24.11.2 submission 希望好运！！！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=24, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTKN1Ot5ibrSUopzI45n7IsLlBeWMbiaN8fDt7NMcfXtn0xCml7jksRXicqvXd8FDPd6xbdP9PFpLDQhg/132, createdBy=20965199906, createdName=扣1992, createdTime=Mon Nov 04 16:00:02 CST 2024, time=2024-11-04, status=1, ipAttribution=黑龙江省), GetPortalCommentsPageByObjectIdResponse(id=2226728, encodeId=278d2226e287a, content=审稿速度:6.0 | 投稿命中率:50.0 偏重的研究方向：肿瘤 经验分享：是不是送审回来后under review的状态就没了了，我送审后一直Editor Review Started快两周了，under review的状态就没了，好焦虑呀, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=43, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=32728759448, createdName=ms2000001407604797, createdTime=Fri Sep 20 11:12:30 CST 2024, time=2024-09-20, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2221474, encodeId=929e22214e4e4, content=已经Decision Made20天了，等得好苦啊 Decision Made 30th Jul 24 Editor Review Started 26th Jul 24 Initial Manuscript Review Started 10th Jul 24 Editor Assigned 8th Jul 24 Submission 5th Jul 24, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=89, replyNumber=14, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f6df8321644, createdName=ms3000001082848798, createdTime=Tue Aug 20 10:12:22 CST 2024, time=2024-08-20, status=1, ipAttribution=辽宁), GetPortalCommentsPageByObjectIdResponse(id=2143170, encodeId=63cd21431e002, content=大佬们觉得这个期刊和昆虫学1区的PBP和PMS哪个好一点啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=98, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3b328275001, createdName=ms6000000883616809, createdTime=Fri Jun 16 17:11:05 CST 2023, time=2023-06-16, status=1, ipAttribution=安徽省), GetPortalCommentsPageByObjectIdResponse(id=2185092, encodeId=3def2185092bd, content=审稿速度:2.0 | 投稿命中率:25.0 偏重的研究方向：肿瘤生物学 经验分享：经验分享，第一轮 Stage Start Date Revision Received 31st Jan 24 Waiting for Revision 31st Jan 24 Decision Made 30th Jan 24 Editor Review Started 13th Jan 24 Initial Manuscript Review Started 8th Jan 24 Editor Assigned 8th Jan 24 Submission 28th Dec 23, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=78, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=608d6458298, createdName=ms1000000620292943, createdTime=Wed Jan 31 20:14:45 CST 2024, time=2024-01-31, status=1, ipAttribution=福建省), GetPortalCommentsPageByObjectIdResponse(id=2222798, encodeId=e8042222e9868, content=偏重的研究方向：肿瘤治疗 经验分享：请问under review一般要等多久呀？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=79, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=5e932497746, createdName=12490d82m03暂无昵称, createdTime=Wed Aug 28 10:56:51 CST 2024, time=2024-08-28, status=1, ipAttribution=湖南省), GetPortalCommentsPageByObjectIdResponse(id=2224533, encodeId=271f222453368, content=审稿速度:12.0 | 投稿命中率:25.0 偏重的研究方向：内质网应激 经验分享：终于接受了，总共三轮审稿，3名审稿人，其中有一个审稿人的问了很多细节的问题，意见真的很专业。WB结果需要没有裁剪过的图片，我是提供了切膜以后拼接起来的图片。个人感觉第一轮审稿很慢，但是投稿体验比之前的国产sci好多了，接受以后10天左右proof，online和检索都非常快速。 第一轮： Revision Received 29th Apr 24 Waiting for Revision 26th Apr 24 Decision Made 26th Apr 24 Editor Review Started 9th Feb 24 Initial Manuscript Review Started 6th Feb 24 Editor Assigned 5th Feb 24 Submission 24th Jan 24 第二轮： Revision Received 6th Aug 24 Waiting for Revision 19th Jul 24 Decision Made 19th Jul 24 Editor Review Started 5th Jul 24 Initial Manuscript Review Started 5th Jul 24 Editor Assigned 5th Jul 24 Submission 3rd Jul 24 第三轮： Post Decision 28th Aug 24 Decision Made 28th Aug 24 Editor Review Started 28th Aug 24 Initial Manuscript Review Started 28th Aug 24 Editor Assigned 28th Aug 24 Submission 6th Aug 24, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=53, replyNumber=12, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3f2e6150418, createdName=ms8000001193267048, createdTime=Sat Sep 07 03:21:06 CST 2024, time=2024-09-07, status=1, ipAttribution=德克萨斯)]

2024-09-20 ms2000001407604797 来自广东省

审稿速度:6.0 | 投稿命中率:50.0
偏重的研究方向：肿瘤
经验分享：是不是送审回来后under review的状态就没了了，我送审后一直Editor Review Started快两周了，under review的状态就没了，好焦虑呀

43 2

展开2条回复

[GetPortalCommentsPageByObjectIdResponse(id=2209514, encodeId=4de22209514ac, content=投稿一个多月后收到审稿意见，4个审稿人，共计三十几条意见，给了六个月的时间来返修。虽然影响因子有点低，但审稿严格，难度还是蛮大的，总感觉性价比不太高。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=85, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=05323119086, createdName=xyzt, createdTime=Wed Jun 12 16:11:14 CST 2024, time=2024-06-12, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2159600, encodeId=0c1b21596007b, content=更新一下，已经原则性接收啦，现在再对应要求改改格式和figures，应该没什么大问题了，更新真的能攒人品啊。 Stage Start Date Waiting for Revision 23rd Sep 23 Decision Made 23rd Sep 23 Editor Review Started 12th Sep 23 Initial Manuscript Review Started 12th Sep 23 Editor Assigned 12th Sep 23 Submission 11th Sep 23 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=115, replyNumber=11, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ad078632381, createdName=ms9000000957475675, createdTime=Mon Sep 25 16:03:17 CST 2023, time=2023-09-25, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2235332, encodeId=e8762235332d7, content=偏重的研究方向：肿瘤转移机制 经验分享：11月3号投稿，好运好运, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=28, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=5b1b5432110, createdName=ms9000001101107383, createdTime=Tue Nov 05 17:33:43 CST 2024, time=2024-11-05, status=1, ipAttribution=加利福尼亚), GetPortalCommentsPageByObjectIdResponse(id=2235109, encodeId=1b7b223510961, content=24.11.2 submission 希望好运！！！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=24, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTKN1Ot5ibrSUopzI45n7IsLlBeWMbiaN8fDt7NMcfXtn0xCml7jksRXicqvXd8FDPd6xbdP9PFpLDQhg/132, createdBy=20965199906, createdName=扣1992, createdTime=Mon Nov 04 16:00:02 CST 2024, time=2024-11-04, status=1, ipAttribution=黑龙江省), GetPortalCommentsPageByObjectIdResponse(id=2226728, encodeId=278d2226e287a, content=审稿速度:6.0 | 投稿命中率:50.0 偏重的研究方向：肿瘤 经验分享：是不是送审回来后under review的状态就没了了，我送审后一直Editor Review Started快两周了，under review的状态就没了，好焦虑呀, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=43, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=32728759448, createdName=ms2000001407604797, createdTime=Fri Sep 20 11:12:30 CST 2024, time=2024-09-20, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2221474, encodeId=929e22214e4e4, content=已经Decision Made20天了，等得好苦啊 Decision Made 30th Jul 24 Editor Review Started 26th Jul 24 Initial Manuscript Review Started 10th Jul 24 Editor Assigned 8th Jul 24 Submission 5th Jul 24, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=89, replyNumber=14, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f6df8321644, createdName=ms3000001082848798, createdTime=Tue Aug 20 10:12:22 CST 2024, time=2024-08-20, status=1, ipAttribution=辽宁), GetPortalCommentsPageByObjectIdResponse(id=2143170, encodeId=63cd21431e002, content=大佬们觉得这个期刊和昆虫学1区的PBP和PMS哪个好一点啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=98, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3b328275001, createdName=ms6000000883616809, createdTime=Fri Jun 16 17:11:05 CST 2023, time=2023-06-16, status=1, ipAttribution=安徽省), GetPortalCommentsPageByObjectIdResponse(id=2185092, encodeId=3def2185092bd, content=审稿速度:2.0 | 投稿命中率:25.0 偏重的研究方向：肿瘤生物学 经验分享：经验分享，第一轮 Stage Start Date Revision Received 31st Jan 24 Waiting for Revision 31st Jan 24 Decision Made 30th Jan 24 Editor Review Started 13th Jan 24 Initial Manuscript Review Started 8th Jan 24 Editor Assigned 8th Jan 24 Submission 28th Dec 23, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=78, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=608d6458298, createdName=ms1000000620292943, createdTime=Wed Jan 31 20:14:45 CST 2024, time=2024-01-31, status=1, ipAttribution=福建省), GetPortalCommentsPageByObjectIdResponse(id=2222798, encodeId=e8042222e9868, content=偏重的研究方向：肿瘤治疗 经验分享：请问under review一般要等多久呀？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=79, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=5e932497746, createdName=12490d82m03暂无昵称, createdTime=Wed Aug 28 10:56:51 CST 2024, time=2024-08-28, status=1, ipAttribution=湖南省), GetPortalCommentsPageByObjectIdResponse(id=2224533, encodeId=271f222453368, content=审稿速度:12.0 | 投稿命中率:25.0 偏重的研究方向：内质网应激 经验分享：终于接受了，总共三轮审稿，3名审稿人，其中有一个审稿人的问了很多细节的问题，意见真的很专业。WB结果需要没有裁剪过的图片，我是提供了切膜以后拼接起来的图片。个人感觉第一轮审稿很慢，但是投稿体验比之前的国产sci好多了，接受以后10天左右proof，online和检索都非常快速。 第一轮： Revision Received 29th Apr 24 Waiting for Revision 26th Apr 24 Decision Made 26th Apr 24 Editor Review Started 9th Feb 24 Initial Manuscript Review Started 6th Feb 24 Editor Assigned 5th Feb 24 Submission 24th Jan 24 第二轮： Revision Received 6th Aug 24 Waiting for Revision 19th Jul 24 Decision Made 19th Jul 24 Editor Review Started 5th Jul 24 Initial Manuscript Review Started 5th Jul 24 Editor Assigned 5th Jul 24 Submission 3rd Jul 24 第三轮： Post Decision 28th Aug 24 Decision Made 28th Aug 24 Editor Review Started 28th Aug 24 Initial Manuscript Review Started 28th Aug 24 Editor Assigned 28th Aug 24 Submission 6th Aug 24, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=53, replyNumber=12, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3f2e6150418, createdName=ms8000001193267048, createdTime=Sat Sep 07 03:21:06 CST 2024, time=2024-09-07, status=1, ipAttribution=德克萨斯)]

2024-08-20 ms3000001082848798 来自辽宁

已经Decision Made20天了，等得好苦啊
Decision Made 30th Jul 24
Editor Review Started 26th Jul 24
Initial Manuscript Review Started 10th Jul 24
Editor Assigned 8th Jul 24
Submission 5th Jul 24

89 14

展开14条回复

[GetPortalCommentsPageByObjectIdResponse(id=2209514, encodeId=4de22209514ac, content=投稿一个多月后收到审稿意见，4个审稿人，共计三十几条意见，给了六个月的时间来返修。虽然影响因子有点低，但审稿严格，难度还是蛮大的，总感觉性价比不太高。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=85, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=05323119086, createdName=xyzt, createdTime=Wed Jun 12 16:11:14 CST 2024, time=2024-06-12, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2159600, encodeId=0c1b21596007b, content=更新一下，已经原则性接收啦，现在再对应要求改改格式和figures，应该没什么大问题了，更新真的能攒人品啊。 Stage Start Date Waiting for Revision 23rd Sep 23 Decision Made 23rd Sep 23 Editor Review Started 12th Sep 23 Initial Manuscript Review Started 12th Sep 23 Editor Assigned 12th Sep 23 Submission 11th Sep 23 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=115, replyNumber=11, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ad078632381, createdName=ms9000000957475675, createdTime=Mon Sep 25 16:03:17 CST 2023, time=2023-09-25, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2235332, encodeId=e8762235332d7, content=偏重的研究方向：肿瘤转移机制 经验分享：11月3号投稿，好运好运, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=28, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=5b1b5432110, createdName=ms9000001101107383, createdTime=Tue Nov 05 17:33:43 CST 2024, time=2024-11-05, status=1, ipAttribution=加利福尼亚), GetPortalCommentsPageByObjectIdResponse(id=2235109, encodeId=1b7b223510961, content=24.11.2 submission 希望好运！！！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=24, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTKN1Ot5ibrSUopzI45n7IsLlBeWMbiaN8fDt7NMcfXtn0xCml7jksRXicqvXd8FDPd6xbdP9PFpLDQhg/132, createdBy=20965199906, createdName=扣1992, createdTime=Mon Nov 04 16:00:02 CST 2024, time=2024-11-04, status=1, ipAttribution=黑龙江省), GetPortalCommentsPageByObjectIdResponse(id=2226728, encodeId=278d2226e287a, content=审稿速度:6.0 | 投稿命中率:50.0 偏重的研究方向：肿瘤 经验分享：是不是送审回来后under review的状态就没了了，我送审后一直Editor Review Started快两周了，under review的状态就没了，好焦虑呀, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=43, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=32728759448, createdName=ms2000001407604797, createdTime=Fri Sep 20 11:12:30 CST 2024, time=2024-09-20, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2221474, encodeId=929e22214e4e4, content=已经Decision Made20天了，等得好苦啊 Decision Made 30th Jul 24 Editor Review Started 26th Jul 24 Initial Manuscript Review Started 10th Jul 24 Editor Assigned 8th Jul 24 Submission 5th Jul 24, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=89, replyNumber=14, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f6df8321644, createdName=ms3000001082848798, createdTime=Tue Aug 20 10:12:22 CST 2024, time=2024-08-20, status=1, ipAttribution=辽宁), GetPortalCommentsPageByObjectIdResponse(id=2143170, encodeId=63cd21431e002, content=大佬们觉得这个期刊和昆虫学1区的PBP和PMS哪个好一点啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=98, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3b328275001, createdName=ms6000000883616809, createdTime=Fri Jun 16 17:11:05 CST 2023, time=2023-06-16, status=1, ipAttribution=安徽省), GetPortalCommentsPageByObjectIdResponse(id=2185092, encodeId=3def2185092bd, content=审稿速度:2.0 | 投稿命中率:25.0 偏重的研究方向：肿瘤生物学 经验分享：经验分享，第一轮 Stage Start Date Revision Received 31st Jan 24 Waiting for Revision 31st Jan 24 Decision Made 30th Jan 24 Editor Review Started 13th Jan 24 Initial Manuscript Review Started 8th Jan 24 Editor Assigned 8th Jan 24 Submission 28th Dec 23, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=78, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=608d6458298, createdName=ms1000000620292943, createdTime=Wed Jan 31 20:14:45 CST 2024, time=2024-01-31, status=1, ipAttribution=福建省), GetPortalCommentsPageByObjectIdResponse(id=2222798, encodeId=e8042222e9868, content=偏重的研究方向：肿瘤治疗 经验分享：请问under review一般要等多久呀？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=79, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=5e932497746, createdName=12490d82m03暂无昵称, createdTime=Wed Aug 28 10:56:51 CST 2024, time=2024-08-28, status=1, ipAttribution=湖南省), GetPortalCommentsPageByObjectIdResponse(id=2224533, encodeId=271f222453368, content=审稿速度:12.0 | 投稿命中率:25.0 偏重的研究方向：内质网应激 经验分享：终于接受了，总共三轮审稿，3名审稿人，其中有一个审稿人的问了很多细节的问题，意见真的很专业。WB结果需要没有裁剪过的图片，我是提供了切膜以后拼接起来的图片。个人感觉第一轮审稿很慢，但是投稿体验比之前的国产sci好多了，接受以后10天左右proof，online和检索都非常快速。 第一轮： Revision Received 29th Apr 24 Waiting for Revision 26th Apr 24 Decision Made 26th Apr 24 Editor Review Started 9th Feb 24 Initial Manuscript Review Started 6th Feb 24 Editor Assigned 5th Feb 24 Submission 24th Jan 24 第二轮： Revision Received 6th Aug 24 Waiting for Revision 19th Jul 24 Decision Made 19th Jul 24 Editor Review Started 5th Jul 24 Initial Manuscript Review Started 5th Jul 24 Editor Assigned 5th Jul 24 Submission 3rd Jul 24 第三轮： Post Decision 28th Aug 24 Decision Made 28th Aug 24 Editor Review Started 28th Aug 24 Initial Manuscript Review Started 28th Aug 24 Editor Assigned 28th Aug 24 Submission 6th Aug 24, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=53, replyNumber=12, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3f2e6150418, createdName=ms8000001193267048, createdTime=Sat Sep 07 03:21:06 CST 2024, time=2024-09-07, status=1, ipAttribution=德克萨斯)]

2023-06-16 ms6000000883616809 来自安徽省

大佬们觉得这个期刊和昆虫学1区的PBP和PMS哪个好一点啊

98 2

展开2条回复

[GetPortalCommentsPageByObjectIdResponse(id=2209514, encodeId=4de22209514ac, content=投稿一个多月后收到审稿意见，4个审稿人，共计三十几条意见，给了六个月的时间来返修。虽然影响因子有点低，但审稿严格，难度还是蛮大的，总感觉性价比不太高。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=85, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=05323119086, createdName=xyzt, createdTime=Wed Jun 12 16:11:14 CST 2024, time=2024-06-12, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2159600, encodeId=0c1b21596007b, content=更新一下，已经原则性接收啦，现在再对应要求改改格式和figures，应该没什么大问题了，更新真的能攒人品啊。 Stage Start Date Waiting for Revision 23rd Sep 23 Decision Made 23rd Sep 23 Editor Review Started 12th Sep 23 Initial Manuscript Review Started 12th Sep 23 Editor Assigned 12th Sep 23 Submission 11th Sep 23 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=115, replyNumber=11, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ad078632381, createdName=ms9000000957475675, createdTime=Mon Sep 25 16:03:17 CST 2023, time=2023-09-25, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2235332, encodeId=e8762235332d7, content=偏重的研究方向：肿瘤转移机制 经验分享：11月3号投稿，好运好运, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=28, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=5b1b5432110, createdName=ms9000001101107383, createdTime=Tue Nov 05 17:33:43 CST 2024, time=2024-11-05, status=1, ipAttribution=加利福尼亚), GetPortalCommentsPageByObjectIdResponse(id=2235109, encodeId=1b7b223510961, content=24.11.2 submission 希望好运！！！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=24, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTKN1Ot5ibrSUopzI45n7IsLlBeWMbiaN8fDt7NMcfXtn0xCml7jksRXicqvXd8FDPd6xbdP9PFpLDQhg/132, createdBy=20965199906, createdName=扣1992, createdTime=Mon Nov 04 16:00:02 CST 2024, time=2024-11-04, status=1, ipAttribution=黑龙江省), GetPortalCommentsPageByObjectIdResponse(id=2226728, encodeId=278d2226e287a, content=审稿速度:6.0 | 投稿命中率:50.0 偏重的研究方向：肿瘤 经验分享：是不是送审回来后under review的状态就没了了，我送审后一直Editor Review Started快两周了，under review的状态就没了，好焦虑呀, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=43, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=32728759448, createdName=ms2000001407604797, createdTime=Fri Sep 20 11:12:30 CST 2024, time=2024-09-20, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2221474, encodeId=929e22214e4e4, content=已经Decision Made20天了，等得好苦啊 Decision Made 30th Jul 24 Editor Review Started 26th Jul 24 Initial Manuscript Review Started 10th Jul 24 Editor Assigned 8th Jul 24 Submission 5th Jul 24, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=89, replyNumber=14, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f6df8321644, createdName=ms3000001082848798, createdTime=Tue Aug 20 10:12:22 CST 2024, time=2024-08-20, status=1, ipAttribution=辽宁), GetPortalCommentsPageByObjectIdResponse(id=2143170, encodeId=63cd21431e002, content=大佬们觉得这个期刊和昆虫学1区的PBP和PMS哪个好一点啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=98, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3b328275001, createdName=ms6000000883616809, createdTime=Fri Jun 16 17:11:05 CST 2023, time=2023-06-16, status=1, ipAttribution=安徽省), GetPortalCommentsPageByObjectIdResponse(id=2185092, encodeId=3def2185092bd, content=审稿速度:2.0 | 投稿命中率:25.0 偏重的研究方向：肿瘤生物学 经验分享：经验分享，第一轮 Stage Start Date Revision Received 31st Jan 24 Waiting for Revision 31st Jan 24 Decision Made 30th Jan 24 Editor Review Started 13th Jan 24 Initial Manuscript Review Started 8th Jan 24 Editor Assigned 8th Jan 24 Submission 28th Dec 23, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=78, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=608d6458298, createdName=ms1000000620292943, createdTime=Wed Jan 31 20:14:45 CST 2024, time=2024-01-31, status=1, ipAttribution=福建省), GetPortalCommentsPageByObjectIdResponse(id=2222798, encodeId=e8042222e9868, content=偏重的研究方向：肿瘤治疗 经验分享：请问under review一般要等多久呀？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=79, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=5e932497746, createdName=12490d82m03暂无昵称, createdTime=Wed Aug 28 10:56:51 CST 2024, time=2024-08-28, status=1, ipAttribution=湖南省), GetPortalCommentsPageByObjectIdResponse(id=2224533, encodeId=271f222453368, content=审稿速度:12.0 | 投稿命中率:25.0 偏重的研究方向：内质网应激 经验分享：终于接受了，总共三轮审稿，3名审稿人，其中有一个审稿人的问了很多细节的问题，意见真的很专业。WB结果需要没有裁剪过的图片，我是提供了切膜以后拼接起来的图片。个人感觉第一轮审稿很慢，但是投稿体验比之前的国产sci好多了，接受以后10天左右proof，online和检索都非常快速。 第一轮： Revision Received 29th Apr 24 Waiting for Revision 26th Apr 24 Decision Made 26th Apr 24 Editor Review Started 9th Feb 24 Initial Manuscript Review Started 6th Feb 24 Editor Assigned 5th Feb 24 Submission 24th Jan 24 第二轮： Revision Received 6th Aug 24 Waiting for Revision 19th Jul 24 Decision Made 19th Jul 24 Editor Review Started 5th Jul 24 Initial Manuscript Review Started 5th Jul 24 Editor Assigned 5th Jul 24 Submission 3rd Jul 24 第三轮： Post Decision 28th Aug 24 Decision Made 28th Aug 24 Editor Review Started 28th Aug 24 Initial Manuscript Review Started 28th Aug 24 Editor Assigned 28th Aug 24 Submission 6th Aug 24, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=53, replyNumber=12, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3f2e6150418, createdName=ms8000001193267048, createdTime=Sat Sep 07 03:21:06 CST 2024, time=2024-09-07, status=1, ipAttribution=德克萨斯)]

2024-01-31 ms1000000620292943 来自福建省

审稿速度:2.0 | 投稿命中率:25.0
偏重的研究方向：肿瘤生物学
经验分享：经验分享，第一轮
Stage Start Date
Revision Received 31st Jan 24
Waiting for Revision 31st Jan 24
Decision Made 30th Jan 24
Editor Review Started 13th Jan 24
Initial Manuscript Review Started 8th Jan 24
Editor Assigned 8th Jan 24
Submission 28th Dec 23

78 5

展开5条回复

[GetPortalCommentsPageByObjectIdResponse(id=2209514, encodeId=4de22209514ac, content=投稿一个多月后收到审稿意见，4个审稿人，共计三十几条意见，给了六个月的时间来返修。虽然影响因子有点低，但审稿严格，难度还是蛮大的，总感觉性价比不太高。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=85, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=05323119086, createdName=xyzt, createdTime=Wed Jun 12 16:11:14 CST 2024, time=2024-06-12, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2159600, encodeId=0c1b21596007b, content=更新一下，已经原则性接收啦，现在再对应要求改改格式和figures，应该没什么大问题了，更新真的能攒人品啊。 Stage Start Date Waiting for Revision 23rd Sep 23 Decision Made 23rd Sep 23 Editor Review Started 12th Sep 23 Initial Manuscript Review Started 12th Sep 23 Editor Assigned 12th Sep 23 Submission 11th Sep 23 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=115, replyNumber=11, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ad078632381, createdName=ms9000000957475675, createdTime=Mon Sep 25 16:03:17 CST 2023, time=2023-09-25, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2235332, encodeId=e8762235332d7, content=偏重的研究方向：肿瘤转移机制 经验分享：11月3号投稿，好运好运, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=28, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=5b1b5432110, createdName=ms9000001101107383, createdTime=Tue Nov 05 17:33:43 CST 2024, time=2024-11-05, status=1, ipAttribution=加利福尼亚), GetPortalCommentsPageByObjectIdResponse(id=2235109, encodeId=1b7b223510961, content=24.11.2 submission 希望好运！！！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=24, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTKN1Ot5ibrSUopzI45n7IsLlBeWMbiaN8fDt7NMcfXtn0xCml7jksRXicqvXd8FDPd6xbdP9PFpLDQhg/132, createdBy=20965199906, createdName=扣1992, createdTime=Mon Nov 04 16:00:02 CST 2024, time=2024-11-04, status=1, ipAttribution=黑龙江省), GetPortalCommentsPageByObjectIdResponse(id=2226728, encodeId=278d2226e287a, content=审稿速度:6.0 | 投稿命中率:50.0 偏重的研究方向：肿瘤 经验分享：是不是送审回来后under review的状态就没了了，我送审后一直Editor Review Started快两周了，under review的状态就没了，好焦虑呀, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=43, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=32728759448, createdName=ms2000001407604797, createdTime=Fri Sep 20 11:12:30 CST 2024, time=2024-09-20, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2221474, encodeId=929e22214e4e4, content=已经Decision Made20天了，等得好苦啊 Decision Made 30th Jul 24 Editor Review Started 26th Jul 24 Initial Manuscript Review Started 10th Jul 24 Editor Assigned 8th Jul 24 Submission 5th Jul 24, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=89, replyNumber=14, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f6df8321644, createdName=ms3000001082848798, createdTime=Tue Aug 20 10:12:22 CST 2024, time=2024-08-20, status=1, ipAttribution=辽宁), GetPortalCommentsPageByObjectIdResponse(id=2143170, encodeId=63cd21431e002, content=大佬们觉得这个期刊和昆虫学1区的PBP和PMS哪个好一点啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=98, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3b328275001, createdName=ms6000000883616809, createdTime=Fri Jun 16 17:11:05 CST 2023, time=2023-06-16, status=1, ipAttribution=安徽省), GetPortalCommentsPageByObjectIdResponse(id=2185092, encodeId=3def2185092bd, content=审稿速度:2.0 | 投稿命中率:25.0 偏重的研究方向：肿瘤生物学 经验分享：经验分享，第一轮 Stage Start Date Revision Received 31st Jan 24 Waiting for Revision 31st Jan 24 Decision Made 30th Jan 24 Editor Review Started 13th Jan 24 Initial Manuscript Review Started 8th Jan 24 Editor Assigned 8th Jan 24 Submission 28th Dec 23, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=78, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=608d6458298, createdName=ms1000000620292943, createdTime=Wed Jan 31 20:14:45 CST 2024, time=2024-01-31, status=1, ipAttribution=福建省), GetPortalCommentsPageByObjectIdResponse(id=2222798, encodeId=e8042222e9868, content=偏重的研究方向：肿瘤治疗 经验分享：请问under review一般要等多久呀？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=79, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=5e932497746, createdName=12490d82m03暂无昵称, createdTime=Wed Aug 28 10:56:51 CST 2024, time=2024-08-28, status=1, ipAttribution=湖南省), GetPortalCommentsPageByObjectIdResponse(id=2224533, encodeId=271f222453368, content=审稿速度:12.0 | 投稿命中率:25.0 偏重的研究方向：内质网应激 经验分享：终于接受了，总共三轮审稿，3名审稿人，其中有一个审稿人的问了很多细节的问题，意见真的很专业。WB结果需要没有裁剪过的图片，我是提供了切膜以后拼接起来的图片。个人感觉第一轮审稿很慢，但是投稿体验比之前的国产sci好多了，接受以后10天左右proof，online和检索都非常快速。 第一轮： Revision Received 29th Apr 24 Waiting for Revision 26th Apr 24 Decision Made 26th Apr 24 Editor Review Started 9th Feb 24 Initial Manuscript Review Started 6th Feb 24 Editor Assigned 5th Feb 24 Submission 24th Jan 24 第二轮： Revision Received 6th Aug 24 Waiting for Revision 19th Jul 24 Decision Made 19th Jul 24 Editor Review Started 5th Jul 24 Initial Manuscript Review Started 5th Jul 24 Editor Assigned 5th Jul 24 Submission 3rd Jul 24 第三轮： Post Decision 28th Aug 24 Decision Made 28th Aug 24 Editor Review Started 28th Aug 24 Initial Manuscript Review Started 28th Aug 24 Editor Assigned 28th Aug 24 Submission 6th Aug 24, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=53, replyNumber=12, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3f2e6150418, createdName=ms8000001193267048, createdTime=Sat Sep 07 03:21:06 CST 2024, time=2024-09-07, status=1, ipAttribution=德克萨斯)]

2024-08-28 12490d82m03暂无昵称来自湖南省

偏重的研究方向：肿瘤治疗
经验分享：请问under review一般要等多久呀？

79 4

展开4条回复

[GetPortalCommentsPageByObjectIdResponse(id=2209514, encodeId=4de22209514ac, content=投稿一个多月后收到审稿意见，4个审稿人，共计三十几条意见，给了六个月的时间来返修。虽然影响因子有点低，但审稿严格，难度还是蛮大的，总感觉性价比不太高。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=85, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=05323119086, createdName=xyzt, createdTime=Wed Jun 12 16:11:14 CST 2024, time=2024-06-12, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2159600, encodeId=0c1b21596007b, content=更新一下，已经原则性接收啦，现在再对应要求改改格式和figures，应该没什么大问题了，更新真的能攒人品啊。 Stage Start Date Waiting for Revision 23rd Sep 23 Decision Made 23rd Sep 23 Editor Review Started 12th Sep 23 Initial Manuscript Review Started 12th Sep 23 Editor Assigned 12th Sep 23 Submission 11th Sep 23 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=115, replyNumber=11, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ad078632381, createdName=ms9000000957475675, createdTime=Mon Sep 25 16:03:17 CST 2023, time=2023-09-25, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2235332, encodeId=e8762235332d7, content=偏重的研究方向：肿瘤转移机制 经验分享：11月3号投稿，好运好运, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=28, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=5b1b5432110, createdName=ms9000001101107383, createdTime=Tue Nov 05 17:33:43 CST 2024, time=2024-11-05, status=1, ipAttribution=加利福尼亚), GetPortalCommentsPageByObjectIdResponse(id=2235109, encodeId=1b7b223510961, content=24.11.2 submission 希望好运！！！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=24, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTKN1Ot5ibrSUopzI45n7IsLlBeWMbiaN8fDt7NMcfXtn0xCml7jksRXicqvXd8FDPd6xbdP9PFpLDQhg/132, createdBy=20965199906, createdName=扣1992, createdTime=Mon Nov 04 16:00:02 CST 2024, time=2024-11-04, status=1, ipAttribution=黑龙江省), GetPortalCommentsPageByObjectIdResponse(id=2226728, encodeId=278d2226e287a, content=审稿速度:6.0 | 投稿命中率:50.0 偏重的研究方向：肿瘤 经验分享：是不是送审回来后under review的状态就没了了，我送审后一直Editor Review Started快两周了，under review的状态就没了，好焦虑呀, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=43, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=32728759448, createdName=ms2000001407604797, createdTime=Fri Sep 20 11:12:30 CST 2024, time=2024-09-20, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2221474, encodeId=929e22214e4e4, content=已经Decision Made20天了，等得好苦啊 Decision Made 30th Jul 24 Editor Review Started 26th Jul 24 Initial Manuscript Review Started 10th Jul 24 Editor Assigned 8th Jul 24 Submission 5th Jul 24, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=89, replyNumber=14, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f6df8321644, createdName=ms3000001082848798, createdTime=Tue Aug 20 10:12:22 CST 2024, time=2024-08-20, status=1, ipAttribution=辽宁), GetPortalCommentsPageByObjectIdResponse(id=2143170, encodeId=63cd21431e002, content=大佬们觉得这个期刊和昆虫学1区的PBP和PMS哪个好一点啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=98, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3b328275001, createdName=ms6000000883616809, createdTime=Fri Jun 16 17:11:05 CST 2023, time=2023-06-16, status=1, ipAttribution=安徽省), GetPortalCommentsPageByObjectIdResponse(id=2185092, encodeId=3def2185092bd, content=审稿速度:2.0 | 投稿命中率:25.0 偏重的研究方向：肿瘤生物学 经验分享：经验分享，第一轮 Stage Start Date Revision Received 31st Jan 24 Waiting for Revision 31st Jan 24 Decision Made 30th Jan 24 Editor Review Started 13th Jan 24 Initial Manuscript Review Started 8th Jan 24 Editor Assigned 8th Jan 24 Submission 28th Dec 23, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=78, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=608d6458298, createdName=ms1000000620292943, createdTime=Wed Jan 31 20:14:45 CST 2024, time=2024-01-31, status=1, ipAttribution=福建省), GetPortalCommentsPageByObjectIdResponse(id=2222798, encodeId=e8042222e9868, content=偏重的研究方向：肿瘤治疗 经验分享：请问under review一般要等多久呀？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=79, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=5e932497746, createdName=12490d82m03暂无昵称, createdTime=Wed Aug 28 10:56:51 CST 2024, time=2024-08-28, status=1, ipAttribution=湖南省), GetPortalCommentsPageByObjectIdResponse(id=2224533, encodeId=271f222453368, content=审稿速度:12.0 | 投稿命中率:25.0 偏重的研究方向：内质网应激 经验分享：终于接受了，总共三轮审稿，3名审稿人，其中有一个审稿人的问了很多细节的问题，意见真的很专业。WB结果需要没有裁剪过的图片，我是提供了切膜以后拼接起来的图片。个人感觉第一轮审稿很慢，但是投稿体验比之前的国产sci好多了，接受以后10天左右proof，online和检索都非常快速。 第一轮： Revision Received 29th Apr 24 Waiting for Revision 26th Apr 24 Decision Made 26th Apr 24 Editor Review Started 9th Feb 24 Initial Manuscript Review Started 6th Feb 24 Editor Assigned 5th Feb 24 Submission 24th Jan 24 第二轮： Revision Received 6th Aug 24 Waiting for Revision 19th Jul 24 Decision Made 19th Jul 24 Editor Review Started 5th Jul 24 Initial Manuscript Review Started 5th Jul 24 Editor Assigned 5th Jul 24 Submission 3rd Jul 24 第三轮： Post Decision 28th Aug 24 Decision Made 28th Aug 24 Editor Review Started 28th Aug 24 Initial Manuscript Review Started 28th Aug 24 Editor Assigned 28th Aug 24 Submission 6th Aug 24, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=53, replyNumber=12, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3f2e6150418, createdName=ms8000001193267048, createdTime=Sat Sep 07 03:21:06 CST 2024, time=2024-09-07, status=1, ipAttribution=德克萨斯)]

2024-09-07 ms8000001193267048 来自德克萨斯

审稿速度:12.0 | 投稿命中率:25.0
偏重的研究方向：内质网应激
经验分享：终于接受了，总共三轮审稿，3名审稿人，其中有一个审稿人的问了很多细节的问题，意见真的很专业。WB结果需要没有裁剪过的图片，我是提供了切膜以后拼接起来的图片。个人感觉第一轮审稿很慢，但是投稿体验比之前的国产sci好多了，接受以后10天左右proof，online和检索都非常快速。
第一轮：
Revision Received 29th Apr 24
Waiting for Revision 26th Apr 24
Decision Made 26th Apr 24
Editor Review Started 9th Feb 24
Initial Manuscript Review Started 6th Feb 24
Editor Assigned 5th Feb 24
Submission 24th Jan 24
第二轮：
Revision Received 6th Aug 24
Waiting for Revision 19th Jul 24
Decision Made 19th Jul 24
Editor Review Started 5th Jul 24
Initial Manuscript Review Started 5th Jul 24
Editor Assigned 5th Jul 24
Submission 3rd Jul 24
第三轮：
Post Decision 28th Aug 24
Decision Made 28th Aug 24
Editor Review Started 28th Aug 24
Initial Manuscript Review Started 28th Aug 24
Editor Assigned 28th Aug 24
Submission 6th Aug 24

53 12

展开12条回复

内科

外科

专科科室

热点

按科室浏览

临床工具

科研工具

其他工具

科研数智化

真实世界研究解决方案

数字化学术传播解决方案

其它

期刊讨论

科室

工具

服务